Deirdre Connelly to join GSK as President, North American Pharmaceuticals
GSK announced, Deirdre Connelly will join the company as President, North American Pharmaceuticals, effective Monday 9 February 2009.
Read the full articleYou might also wanna read
GSK in talks to acquire Nuvalent for over $9 billion in largest deal in more than a decade
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to
cnbc.com·1mo ago
GSK acquires cancer drug developer Nuvalent in $10.6 billion deal
Biotech firm is developing small molecules for lung cancers
cen.acs.org·29d ago
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
Deal would rank as one of UK drugmaker’s biggest as biotech M&A activity accelerates this year
ft.trib.al·1mo ago
GSK agrees $10 billion deal for Nuvalent cancer drugs
Deal includes two late-stage molecules to augment GSK’s renewed cancer therapy pipeline
Bio Usawa appoints former Pfizer chief medical officer Dr. Aida Habtezion to board of directors
KIGALI, Rwanda and SAN FRANCISCO, June 15, 2026 (GLOBE NEWSWIRE) — Bio Usawa, a biotechnology company dedicated to expanding access to high-
financialpost.com·24d ago
Lisa Smith Appointed as New President of D&AD for 2025-2026
The design heavyweight steps into the presidency with a mission to guide the organisation through a time of massive cultural shifts, emergin
Creative Boom·9mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.